| Valuation method | Value, € | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 30.48 | 2118 |
| Intrinsic value (DCF) | 0.73 | -47 |
| Graham-Dodd Method | 0.16 | -88 |
| Graham Formula | 0.00 | -100 |
BIO-UV Group S.A. is a French leader in ultraviolet (UV) light water and surface treatment systems, specializing in innovative disinfection solutions for both individual and professional use. Founded in 2000 and headquartered in Lunel, France, the company operates in the waste management sector under the industrials umbrella. BIO-UV Group offers a diverse portfolio of UV treatment products, including O'Clear UV for water disinfection, DELTA-UV for pools and spas, and BIO-SEA for ballast water treatment in maritime applications. The company also provides solutions for industrial process water, wastewater disinfection, and surface disinfection for healthcare, hospitality, and transport sectors. With a strong focus on sustainability, BIO-UV Group's chlorine-free and energy-efficient UV systems cater to a growing global demand for eco-friendly water treatment solutions. The company's presence in multiple segments—residential, commercial, and industrial—positions it as a versatile player in the UV disinfection market.
BIO-UV Group presents a niche investment opportunity in the UV water treatment sector, benefiting from increasing regulatory and consumer demand for sustainable disinfection solutions. The company's diversified product portfolio and specialization in chlorine-free systems provide a competitive edge. However, investors should note the company's lack of profitability (zero net income and diluted EPS in the latest period) and high total debt (€28.27M) relative to its market cap (€27.46M). Positive operating cash flow (€6.9M) and moderate beta (0.396) suggest some resilience, but the absence of dividends may deter income-focused investors. The stock could appeal to those bullish on environmental technology trends, though financial stability remains a concern.
BIO-UV Group competes in the UV disinfection market with a focus on specialized, eco-friendly solutions. Its competitive advantage lies in its broad product range, covering residential, commercial, and industrial applications—unlike many peers that target only one segment. The company's BIO-SEA line for maritime ballast water treatment is a standout, addressing stringent international regulations on invasive species. However, its small market cap and limited geographic footprint (primarily France) constrain its ability to compete with global players in scaling production or R&D investments. While its chlorine-free systems align with sustainability trends, competitors with stronger balance sheets may outpace BIO-UV in innovation and market expansion. The lack of profitability further limits its capacity to invest in growth, making it a smaller, more specialized player in a market increasingly dominated by multinationals.